GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

INSM · Sep 30, 2022

INSMED Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104506-22-000023General Corporate
Debt relative to revenue47thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.debt_to_revenue

1181.16% · OPTIONAL · VALID

Capex intensity0thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.86% · OPTIONAL · VALID

Operating cash generation93thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-132.63% · OPTIONAL · VALID

Revenue growth82thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

44.86% · CORE · VALID

Inventory pressure60thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

97.85% · OPTIONAL · VALID

Operating margin47thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.operating_margin

-188.54% · CORE · VALID

R&D intensity73thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

147.46% · OPTIONAL · VALID

SBC intensity40thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

23.11% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
1226.60%
Current
1181.16%
Delta
-45.44%
Capex Intensity Decreased
Previous
4.45%
Current
0.86%
Delta
-3.59%
Cash Generation Increased
Previous
-156.85%
Current
-132.63%
Delta
24.23%
Growth Increased
Previous
43.77%
Current
44.86%
Delta
1.09%
Inventory Pressure Decreased
Previous
102.75%
Current
97.85%
Delta
-4.90%
Profitability Decreased
Previous
-135.41%
Current
-188.54%
Delta
-53.13%
R And D Intensity Increased
Previous
135.73%
Current
147.46%
Delta
11.72%
Sbc Intensity Increased
Previous
21.86%
Current
23.11%
Delta
1.25%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · INSM Fundamental State →Has State · INSMED Inc →Transitioned To · INSM Fundamental State →Transitioned To · INSM BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · INSM CAPEX_INTENSITY_DECREASED →Transitioned To · INSM CASH_GENERATION_INCREASED →Transitioned To · INSM GROWTH_INCREASED →Transitioned To · INSM INVENTORY_PRESSURE_DECREASED →Transitioned To · INSM PROFITABILITY_DECREASED →Transitioned To · INSM R_AND_D_INTENSITY_INCREASED →Transitioned To · INSM SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.